Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-022797
Filing Date
2022-06-16
Accepted
2022-06-16 16:06:10
Documents
1
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4519
  Complete submission text file 0000899243-22-022797.txt   5929
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O KYMERA THERAPEUTICS, INC. 200 ARSENAL YARDS, SUITE 230 WATERTOWN MA 02472
Business Address
Hrustanovic Gorjan (Reporting) CIK: 0001821194 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 221020583